🇺🇸 FDA
Pipeline program

FLUOROURACIL , OXALIPLATIN , ABTL0812 Placebo, ABTL0812, IRINOTECAN , CALCIUM FOLINATE

ABT-C11-2020

Phase 2 small_molecule active

Quick answer

FLUOROURACIL , OXALIPLATIN , ABTL0812 Placebo, ABTL0812, IRINOTECAN , CALCIUM FOLINATE for Metastatic pancreatic ductal adenocarcinoma is a Phase 2 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Metastatic pancreatic ductal adenocarcinoma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials